Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas

SIMPLE SUMMARY: This clinical investigation reports the results of a prospective, multicenter phase II trial designed to evaluate the activity and safety of combining non-pegylated liposomal doxorubicin (NPLD) with ifosfamide as a first-line treatment for advanced/metastatic STS. The study results d...

Descripción completa

Detalles Bibliográficos
Autores principales: Buonadonna, Angela, Scalone, Simona, Lombardi, Davide, Fumagalli, Arianna, Guglielmi, Alessandra, Lestuzzi, Chiara, Polesel, Jerry, Canzonieri, Vincenzo, Lamon, Stefano, Giovanis, Petros, Gagno, Sara, Corona, Giuseppe, Mascarin, Maurizio, Belluco, Claudio, De Paoli, Antonino, Fasola, Gianpiero, Puglisi, Fabio, Miolo, Gianmaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605752/
https://www.ncbi.nlm.nih.gov/pubmed/37894403
http://dx.doi.org/10.3390/cancers15205036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605752/
https://www.ncbi.nlm.nih.gov/pubmed/37894403
http://dx.doi.org/10.3390/cancers15205036

Ejemplares similares